Iovance Biotherapeutics Inc. sell StockNews.com
Start price
01.07.23
/
50%
€6.50
Target price
01.07.24
-
Performance (%)
16.15%
End price
02.07.24
€7.55
Summary
This prediction ended on 02.07.24 with a price of €7.55. The prediction closed with a disappointing performance of 16.15%. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Iovance Biotherapeutics Inc. | 35.689% | 35.689% | 254.407% | 37.437% |
| iShares Core DAX® | -1.586% | 5.028% | 6.332% | 64.061% |
| iShares Nasdaq 100 | -4.148% | -0.125% | 25.735% | 86.918% |
| iShares Nikkei 225® | -6.302% | 0.528% | 41.384% | 77.872% |
| iShares S&P 500 | -3.225% | 0.470% | 20.449% | 68.192% |
Comments by StockNews_com for this prediction
In the thread Iovance Biotherapeutics Inc. diskutieren
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for IOVA provided by MarketBeat
In the thread Trading Iovance Biotherapeutics Inc.
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten
Stopped prediction by StockNews_com for Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€5.52
09.09.23
09.09.23
-
09.09.24
09.09.24
47.24%
10.09.24
10.09.24

